1. Signaling Pathways
  2. Apoptosis
  3. Caspase
  4. Caspase 12 Isoform

Caspase 12

Caspase-12 belongs to the inflammatory caspase group, but its biology differs from caspase-1, -4, -5, and -11 because it can attenuate endotoxin-induced cytokine production rather than directly promote cytokine maturation[1][2]. Mechanistically, human full-length Caspase-12 reduced lipopolysaccharide-stimulated cytokine production in ex vivo whole blood and was linked to severe sepsis risk in African American individuals[1]. In viral immunity, mouse Caspase-12 controlled West Nile virus infection by regulating TRIM25-mediated RIG-I ubiquitination and type I interferon production[3]. ER-stress studies connect Caspase-12 with apoptosis, because overexpressed full-length caspase-12 underwent processing and ER-stress models showed caspase-12-associated caspase-3 activation[4][5]. In intestinal inflammation, IKKα loss increased unfolded protein response and caspase-12 activation, reducing protective IL-18 secretion during acute colitis[6]. Compared with caspase-1 and caspase-11, however, triple-knockout mouse data found no additional caspase-12 contribution to LPS response, apoptosis, necroptosis, or tunicamycin-induced ER stress in that model[7]. For experimental applications, caspase-12 inhibition with Z-ATAD-FMK reduced oxygen-glucose-deprivation injury, apoptosis, NLRP3, caspase-1, IL-1β, and cleaved caspase-3 in primary astrocytes[8].

Caspase 12 Related Products (3):

Cat. No. Product Name Effect Purity
  • HY-12305
    Q-VD-OPh
    Inhibitor 99.92%
    Q-VD-OPh is an irreversible pan-caspase inhibitor with potent antiapoptotic properties; inhibits caspase 7 with an IC50 of 48 nM and 25-400 nM for other caspases including caspase 1, 3, 8, 9, 10, and 12. Q-VD-OPh can inhibits HIV infection. Q-VD-OPh is able to cross the blood-brain barrier.
  • HY-19696
    Tauroursodeoxycholate
    Inhibitor 99.93%
    Tauroursodeoxycholate (Tauroursodeoxycholic acid) is an orally active endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.
  • HY-19696A
    Tauroursodeoxycholate sodium
    Inhibitor 98.40%
    Tauroursodeoxycholate (Tauroursodeoxycholic acid; TUDCA) sodium is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.